Clinical Trial Update: Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating prolonged inhaled nitric oxide gas and its effects on plasma redox reactions in cardiac surgical patients has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Endothelial Dysfunction
• Oxidative Stress

Drugs mentioned

• Nitric oxide inhalation (nitric oxide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cardiovascular Diseases, Oxidative Stress | Phase 2 | Status: WITHDRAWN